Search research articles
Contact Us
Filters
Showing results (61-70 of 147) with videos related to
Page
of 15
Sort By:
Molecular & Cellular Proteomics : MCP
|
December 24, 2016
Vascular Endothelial Growth Factor (VEGF) Promotes Assembly of the p130Cas Interactome to Drive Endothelial Chemotactic Signaling and Angiogenesis
Ian M Evans, Susan A Kennedy, Ketevan Paliashvili, et al.
Cells
|
May 3, 2014
Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation
Helen M Jopling, Adam F Odell, Caroline Pellet-Many, et al.
Advances in Radiation Oncology
|
January 24, 2022
A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses
Joseph Chao, Ting-Fang He, Massimo D'Apuzzo, et al.
Cancer Chemotherapy and Pharmacology
|
September 18, 2012
Phase I study of nelfinavir in liposarcoma
Janet Pan, Michelle Mott, Bixin Xi, et al.
The Journal of Infectious Diseases
|
August 11, 2021
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience
Alfredo G Puing, Stephanie Ho, Paul Frankel, et al.
Journal for Immunotherapy of Cancer
|
March 24, 2021
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer
Colt Egelston, Weihua Guo, Susan Yost, et al.
Oncology
|
April 20, 2016
Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma
Vincent Chung, Paul Frankel, Dean Lim, et al.
Anticancer Research
|
February 13, 2010
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors
Thehang Luu, Warren Chow, Dean Lim, et al.
Cancer Genetics
|
March 21, 2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival
Joyce Liu, Mihaela C Cristea, Paul Frankel, et al.
Oncogene
|
May 4, 2018
Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades
Ningning Li, Ying Zhang, Kastytis Sidlauskas, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 147) with videos related to
Sort By:
Page
of 15
Molecular & Cellular Proteomics : MCP
|
December 24, 2016
Vascular Endothelial Growth Factor (VEGF) Promotes Assembly of the p130Cas Interactome to Drive Endothelial Chemotactic Signaling and Angiogenesis
Ian M Evans, Susan A Kennedy, Ketevan Paliashvili, et al.
Cells
|
May 3, 2014
Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation
Helen M Jopling, Adam F Odell, Caroline Pellet-Many, et al.
Advances in Radiation Oncology
|
January 24, 2022
A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses
Joseph Chao, Ting-Fang He, Massimo D'Apuzzo, et al.
Cancer Chemotherapy and Pharmacology
|
September 18, 2012
Phase I study of nelfinavir in liposarcoma
Janet Pan, Michelle Mott, Bixin Xi, et al.
The Journal of Infectious Diseases
|
August 11, 2021
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience
Alfredo G Puing, Stephanie Ho, Paul Frankel, et al.
Journal for Immunotherapy of Cancer
|
March 24, 2021
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer
Colt Egelston, Weihua Guo, Susan Yost, et al.
Oncology
|
April 20, 2016
Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma
Vincent Chung, Paul Frankel, Dean Lim, et al.
Anticancer Research
|
February 13, 2010
Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors
Thehang Luu, Warren Chow, Dean Lim, et al.
Cancer Genetics
|
March 21, 2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival
Joyce Liu, Mihaela C Cristea, Paul Frankel, et al.
Oncogene
|
May 4, 2018
Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades
Ningning Li, Ying Zhang, Kastytis Sidlauskas, et al.
Page
of 15